Aptimmune Biologics' Series B Round

Aptimmune Biologics raised a round of funding on January 23, 2018.

Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine. The company's current focus is bringing into the market effective prophylax…

Articles about Aptimmune Biologics' Series B Round: